BDX Q1 2023 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.6B-2.8% YoY

Gross Profit

$2.1B46.5% margin

Operating Income

$585M12.8% margin

Net Income

$509M11.1% margin

EPS (Diluted)

$1.70

QoQ Revenue Growth

-3.7%

Cash Flow

Operating Cash Flow

$400M

Free Cash Flow

$192M

Stock-Based Comp.

$89M

Balance Sheet

Total Assets

$53.1B

Total Liabilities

$27.7B

Stockholders' Equity

$25.5B

Cash & Equivalents

$612M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.6B	$4.7B	-2.8%
Gross Profit	$2.1B	$2.2B	-3.9%
Operating Income	$585M	$692M	-15.5%
Net Income	$509M	$677M	-24.8%

Revenue Segments

Medical

$2.2B47%

Life Sciences

$1.3B28%

Interventional

$1.1B25%

Geographic Segments

UNITED STATES

$2.7B60%

Non-US

$1.9B40%